Given the prominent role of Notch1 and Notch3 signaling in physiological development of many tissues and in pathogenesis, chemo-resistance and relapse of different human cancers, including T-ALL, many efforts have been paid to unveil molecular mechanisms priming their activation or sustaining the strength and the activity of their signaling (1). The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.